Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Prostate Cancer

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    May 2019
  1. GOODMAN PJ, Tangen CM, Thompson IM Jr
    More on Long-Term Effects of Finasteride on Prostate Cancer Mortality. Reply.
    N Engl J Med. 2019;380:e38.
    PubMed     Text format    


  2. GARNICK MB
    More on Long-Term Effects of Finasteride on Prostate Cancer Mortality.
    N Engl J Med. 2019;380:e38.
    PubMed     Text format    


  3. STAPFF MP, Palm S
    More on Long-Term Effects of Finasteride on Prostate Cancer Mortality.
    N Engl J Med. 2019;380:e38.
    PubMed     Text format    


    March 2019
  4. BILL-AXELSON A, Holmberg L, Garmo H
    Radical Surgery or Watchful Waiting in Prostate Cancer. Reply.
    N Engl J Med. 2019;380:1084.
    PubMed     Text format    


  5. CHARKES ND
    Radical Surgery or Watchful Waiting in Prostate Cancer.
    N Engl J Med. 2019;380:1084.
    PubMed     Text format    


  6. YANG Z, McCaw ZR, Yin G
    Radical Surgery or Watchful Waiting in Prostate Cancer.
    N Engl J Med. 2019;380:1083-1084.
    PubMed     Text format    


    February 2019
  7. FIZAZI K, Shore N, Tammela TL, Ulys A, et al
    Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
    N Engl J Med. 2019 Feb 14. doi: 10.1056/NEJMoa1815671.
    PubMed     Text format     Abstract available


    January 2019
  8. GOODMAN PJ, Tangen CM, Darke AK, Lucia MS, et al
    Long-Term Effects of Finasteride on Prostate Cancer Mortality.
    N Engl J Med. 2019;380:393-394.
    PubMed     Text format    


    December 2018
  9. BILL-AXELSON A, Holmberg L, Garmo H, Taari K, et al
    Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.
    N Engl J Med. 2018;379:2319-2329.
    PubMed     Text format     Abstract available


    October 2018

  10. Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380-1381.
    PubMed     Text format    


  11. BREGNI G, Rebuzzi SE, Fornarini G
    Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380-1.
    PubMed     Text format    


  12. ANKER MS, Lehmann LH, Ander SD
    Enzalutamide in Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;379:1380.
    PubMed     Text format    


    September 2018
  13. VEDULA R, Vaidya A, Galetta K, Laubach J, et al
    A Sticky Situation.
    N Engl J Med. 2018;379:e22.
    PubMed     Text format    


  14. ANTONARAKIS ES
    Cyclin-Dependent Kinase 12, Immunity, and Prostate Cancer.
    N Engl J Med. 2018;379:1087-1089.
    PubMed     Text format    


    August 2018
  15. VICKERS A, Ehdaie B
    MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589.
    PubMed     Text format    


  16. MARTINI A, Cumarasamy S, Tewari AK
    MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589.
    PubMed     Text format    



  17. MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018;379:589-590.
    PubMed     Text format    


    June 2018
  18. RACHNER TD, Tsourdi E, Hofbauer LC
    Apalutamide and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018;378:2541-2.
    PubMed     Text format    



  19. Apalutamide and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018;378:2541-2542.
    PubMed     Text format    


  20. HUSSAIN M, Fizazi K, Saad F, Rathenborg P, et al
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
    N Engl J Med. 2018;378:2465-2474.
    PubMed     Text format     Abstract available


  21. BEAVER JA, Kluetz PG, Pazdur R
    Metastasis-free Survival - A New End Point in Prostate Cancer Trials.
    N Engl J Med. 2018;378:2458-2460.
    PubMed     Text format    


  22. SMITH MR
    Progress in Nonmetastatic Prostate Cancer.
    N Engl J Med. 2018;378:2531-2532.
    PubMed     Text format    


    May 2018
  23. BARRY MJ, Rosenkrantz AB
    MRI-Targeted versus Ultrasonography-Guided Biopsy for Suspected Prostate Cancer.
    N Engl J Med. 2018;378:1835-1836.
    PubMed     Text format    


  24. SMITH TJ, Loprinzi CL, Deville C
    Oxybutynin for Hot Flashes Due to Androgen Deprivation in Men.
    N Engl J Med. 2018;378:1745-1746.
    PubMed     Text format    


    April 2018
  25. RODRIGUEZMORENO JF, GarciaDonas J
    Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653.
    PubMed     Text format    


  26. ABATE-SHEN C
    Prostate Cancer Metastasis - Fueled by Fat?
    N Engl J Med. 2018;378:1643-1645.
    PubMed     Text format    



  27. Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653-1654.
    PubMed     Text format    


    March 2018
  28. KASIVISVANATHAN V, Rannikko AS, Borghi M, Panebianco V, et al
    MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
    N Engl J Med. 2018 Mar 18. doi: 10.1056/NEJMoa1801993.
    PubMed     Text format     Abstract available


    February 2018
  29. CHEN D, Ayala GE
    Innervating Prostate Cancer.
    N Engl J Med. 2018;378:675-677.
    PubMed     Text format    


  30. SMITH MR, Saad F, Chowdhury S, Oudard S, et al
    Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
    N Engl J Med. 2018 Feb 8. doi: 10.1056/NEJMoa1715546.
    PubMed     Text format     Abstract available


  31. SARTOR O, de Bono JS
    Metastatic Prostate Cancer.
    N Engl J Med. 2018 Feb 7. doi: 10.1056/NEJMra1701695.
    PubMed     Text format    


    October 2017
  32. FIZAZI K, Chi KN
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1697-8.
    PubMed     Text format    


  33. ISMAILI N, Guessous F
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1695-6.
    PubMed     Text format    


  34. TANNOCK IF
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1695.
    PubMed     Text format    


  35. DE BONO J, Eisenberger M, Sartor O
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1694-5.
    PubMed     Text format    


  36. JAMES ND, Spears MR, Sydes MR
    Abiraterone in Metastatic Prostate Cancer.
    N Engl J Med. 2017;377:1696-7.
    PubMed     Text format    


    September 2017
  37. SHARMA V, Karnes RJ
    Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1302.
    PubMed     Text format    



  38. Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1301-1303.
    PubMed     Text format    


  39. WALLIS CJD, Klotz L
    Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:1301-2.
    PubMed     Text format    


    July 2017
  40. LOGOTHETIS CJ
    Improved Outcomes in Men with Advanced Prostate Cancer.
    N Engl J Med. 2017;377:388-390.
    PubMed     Text format    


  41. HAYMART MR, Miller DC, Hawley ST
    Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment?
    N Engl J Med. 2017;377:203-206.
    PubMed     Text format    


  42. WILT TJ, Jones KM, Barry MJ, Andriole GL, et al
    Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
    N Engl J Med. 2017;377:132-142.
    PubMed     Text format     Abstract available


    June 2017
  43. PINSKY PF, Prorok PC, Kramer BJ
    Prostate Cancer Screening.
    N Engl J Med. 2017;376:2402.
    PubMed     Text format    


  44. WALSH PC
    Prostate Cancer Screening.
    N Engl J Med. 2017;376:2401-2.
    PubMed     Text format    


  45. FIZAZI K, Tran N, Fein L, Matsubara N, et al
    Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
    N Engl J Med. 2017 Jun 4. doi: 10.1056/NEJMoa1704174.
    PubMed     Text format     Abstract available


  46. JAMES ND, de Bono JS, Spears MR, Clarke NW, et al
    Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    N Engl J Med. 2017 Jun 3. doi: 10.1056/NEJMoa1702900.
    PubMed     Text format     Abstract available


    March 2017
  47. PINSKY PF, Prorok PC, Kramer BS
    Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
    N Engl J Med. 2017;376:1285-1289.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: